{"pub": "businessinsider", "url": "https://businessinsider.com/gsk-to-sell-two-travel-vaccines-to-danish-biotech-firm-2019-10", "downloaded_at": "2019-10-21 10:31:36.280912+00:00", "title": "GSK to sell two travel vaccines to Danish biotech firm", "language": "en", "text": "FILE PHOTO: The GSK logo is seen on top of GSK Asia House in Singapore Reuters\n\n(Reuters) - GlaxoSmithKline Plc said on Monday it will sell two travel vaccines to Denmark-based biotechnology company Bavarian Nordic for an upfront payment of 301 million euros ($335.71 million).\n\nThe sale of anti-rabies treatment Rabipur and Encepur, used for the prevention of tick-borne encephalitis, by the British drugmaker includes milestone payments of up to 495 million euros.\n\n(Reporting by Aakash Jagadeesh Babu in Bengaluru; Editing by Arun Koyyur)", "description": "(Reuters) - GlaxoSmithKline Plc said on Monday it will sell two travel vaccines to Denmark-based biotechnology company Bavarian Nordic for an upfront payment of 301 million euros  ($335.71 million).", "authors": [], "top_image": "https://www.businessinsider.com/public/assets/BI/US/og-image-logo-social.png", "published_at": "2019-10-21"}